Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
出版年份 2019 全文链接
标题
Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
作者
关键词
-
出版物
Cancer Cell International
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-06
DOI
10.1186/s12935-019-1009-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction
- (2018) Rong Fan et al. DNA AND CELL BIOLOGY
- BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy
- (2018) Taylor C. Brown et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
- (2017) Chao Yang et al. Cell Death & Disease
- miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models
- (2017) Xuan Liu et al. Scientific Reports
- Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9
- (2016) Jianming Wang et al. Molecular Medicine Reports
- Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interaction Inhibitors
- (2016) John A. Wisniewski et al. ACS Medicinal Chemistry Letters
- BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
- (2016) XIAO-HUI LING et al. Oncology Letters
- BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer
- (2015) Andreas E. Moor et al. EBioMedicine
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
- (2013) Jiyeon Hyeon et al. Korean Journal of Pathology
- Multiple Functions of BCL-2 Family Proteins
- (2013) J. M. Hardwick et al. Cold Spring Harbor Perspectives in Biology
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-30c-2* Expressed in Ovarian Cancer Cells Suppresses Growth Factor-Induced Cellular Proliferation and Downregulates the Oncogene BCL9
- (2011) W. Jia et al. MOLECULAR CANCER RESEARCH
- Analysis of the Interaction of BCL9 with β-Catenin and Development of Fluorescence Polarization and Surface Plasmon Resonance Binding Assays for this Interaction
- (2009) Steven A. Kawamoto et al. BIOCHEMISTRY
- BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
- (2009) M. Mani et al. CANCER RESEARCH
- The PHD domain is required to link Drosophila Pygopus to Legless/β-catenin and not to histone H3
- (2009) Roman Kessler et al. MECHANISMS OF DEVELOPMENT
- β-Catenin hits chromatin: regulation of Wnt target gene activation
- (2009) Christian Mosimann et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A role of Pygopus as an anti-repressor in facilitating Wnt-dependent transcription
- (2008) J. Mieszczanek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now